المؤلفون: Thomas J. Ettrich, Jens Atzpodien, Stephan Kanzler, Swen Wessendorf, Swantje Held, Petra Buechner-Steudel, Axel Florschütz, D Nörenberg, Max Seidensticker, Anke Reinacher-Schick, Jorge Riera-Knorrenschild, Dominik Paul Modest, Michael Geissler, J. Greeve, Uwe M. Martens, Volker Heinemann, Sebastian Stintzing, Andrea Tannapfel, Annika Kurreck, Thomas Seufferlein

المصدر: Journal of Cancer Research and Clinical Oncology

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Organoplatinum Compounds, Colorectal cancer, Original Article – Clinical Oncology, Leucovorin, Disease, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Disease dynamics, FOLFOXIRI, Metastatic colorectal cancer, Panitumumab, General Medicine, Middle Aged, Primary tumor, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Female, Fluorouracil, Colorectal Neoplasms, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Randomization, BRAF, Combination chemotherapy, 03 medical and health sciences, Internal medicine, medicine, Humans, Aged, business.industry, Wild type, medicine.disease, Early tumor shrinkage, 030104 developmental biology, Tumor progression, Mutation, Primary tumor site, ras Proteins, Camptothecin, business, Depth of response

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6834639b3ec002c9bc256673519e750Test
https://doi.org/10.1007/s00432-020-03257-zTest

المؤلفون: Helmut Friess, Dirk Waldschmidt, Holger Schulz, Martin Fuchs, Eray Goekkurt, Thomas Geer, Volker Heinemann, Wolfgang Blau, Marcel Reiser, Metin Senkal, Uwe Pelzer, Ralf Jakobs, Michael Stahl, Matthias Egger, Swantje Held, Jens T. Siveke, Ralph Keller, Christina Große-Thie, Thomas J. Ettrich, Stefan Boeck, Hubert J. Stein, Ingo Hartlapp, Georg Maschmeyer, Peter Fix, Thomas Südhoff, U. Lindig, Elke Hennes, Marcus Bahra, Volker Kunzmann, Ingo Klein, Frank Kullmann, Gabriele Margareta Siegler, Christoph Kahl, Hana Algül, Christoph-Thomas Germer, Uwe M. Martens, Stefan Mahlmann

المساهمون: Stahl, Michael (Beitragende*r), Mahlmann, Stefan (Beitragende*r)

مصطلحات موضوعية: Male, FOLFIRINOX, Leucovorin, Medizin, Phases of clinical research, Deoxycytidine, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Aged, 80 and over, education.field_of_study, Induction Chemotherapy, Middle Aged, Neoadjuvant Therapy, Oxaliplatin, Treatment Outcome, 030220 oncology & carcinogenesis, Female, 030211 gastroenterology & hepatology, Fluorouracil, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Paclitaxel, Population, Antineoplastic Agents, Adenocarcinoma, Irinotecan, Drug Administration Schedule, Young Adult, 03 medical and health sciences, Pancreatectomy, Albumins, Internal medicine, medicine, Humans, education, Aged, Neoplasm Staging, Hepatology, business.industry, Induction chemotherapy, medicine.disease, Gemcitabine, Pancreatic Neoplasms, business, Progressive disease, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1066cfe3208263c113f5fd0c464ccbd8Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85099144148Test

المؤلفون: Hans-Heinrich Wolf, Manfred Binder, Gabriele Ihorst, Johannes Bloehdorn, Martina Deckert, Benjamin Kasenda, Anke Morgner, Johannes Atta, Ulrich Keller, Juergen Finke, Peter Hau, Kristina Fritsch, Alexander Röth, Carsten Hirt, Gerald Illerhaus, Norbert Frickhofen, Löw S, Jens Panse, Ralph Naumann, Heß G, Stephanie Sasse, Uwe M. Martens, Stefan W. Krause, Claudia Hader, Monika Lamprecht, Heidi Fricker, Elisabeth Schorb, Robert Möhle

المصدر: Leukemia
Leukemia : normal and malignant hemopoiesis 31(4), 846-852 (2017). doi:10.1038/leu.2016.334

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Lymphoma, Population, Medizin, Procarbazine, Gastroenterology, Central Nervous System Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Immunologic Factors, education, Aged, Neoplasm Staging, Proportional Hazards Models, Aged, 80 and over, education.field_of_study, Hematology, business.industry, Remission Induction, Primary central nervous system lymphoma, Lomustine, medicine.disease, Surgery, Tumor Burden, Methotrexate, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Cytarabine, Quality of Life, Rituximab, Original Article, Female, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b788727f36c75ddb2bbdc7cd8e48373Test
http://europepmc.org/articles/PMC5383936Test

المؤلفون: Murielle Mauer, Markus Moehler, Peter C. Thuss-Patience, Uwe M. Martens, Sun Young Rha, Heike I. Grabsch, Anna Dorothea Wagner, Florian Lordick, Carmela Caballero, Lothar Mueller, Annemieke Cats, Yoon-Koo Kang, Masanori Tokunaga, Sandrine Marreaud, Annelie Elme

المساهمون: Pathologie, RS: GROW - R2 - Basic and Translational Cancer Biology

المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer, 19:494. BioMed Central Ltd
BMC Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Esophageal Neoplasms, Receptor, ErbB-2, SURGERY, medicine.medical_treatment, Gastroenterology, Study Protocol, NEOADJUVANT CHEMOTHERAPY, Antineoplastic Agents, Immunological, 0302 clinical medicine, FOLFOX, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, OXALIPLATIN, Netherlands, Aged, 80 and over, DOCETAXEL, Middle Aged, OPEN-LABEL, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Chemotherapy regimen, Neoadjuvant Therapy, Progression-Free Survival, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, Gastro-esophageal junction cancer, Esophagogastric Junction, Fluorouracil, Pertuzumab, medicine.drug, Adult, medicine.medical_specialty, Antineoplastic Agents, CAPECITABINE, Adenocarcinoma, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Capecitabine, Young Adult, 03 medical and health sciences, Breast cancer, Stomach Neoplasms, Internal medicine, HER2, Republic of Korea, REGRESSION, Genetics, medicine, Humans, BREAST-CANCER, Perioperative Period, Aged, Cisplatin, Chemotherapy, Perioperative chemotherapy, business.industry, Trastuzumab, medicine.disease, Oxaliplatin, 030104 developmental biology, business, Gastric cancer, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98819406c91ecd11f368ecbad6cc7175Test
https://eprints.whiterose.ac.uk/151178/1/wrro_151178.pdfTest

المؤلفون: Igor Wolfgang Blau, Katja Weisel, Jan Duerig, Mathias Haenel, Roland Fenk, Uta Bertsch, Christina Kunz, Stefanie Huhn, Marc S. Raab, Hartmut Goldschmidt, Uwe M. Martens, Ullrich Graeven, Manfred Hensel, Stefan Fronhoffs, Jens Hillengass, Mohammed Wattad, Hans Salwender, Markus Munder, Anna Jauch, Hans-Walter Lindemann, Timon Hansen, Dirk Hose, Christof Scheid, Axel Benner, Mindaugas Andrulis, Michael Hundemer, Andrea Seidel-Glaetzer

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_treatment, Medizin, Dexamethasone, Bortezomib, Study Protocol, 610 Medical sciences Medicine, 0302 clinical medicine, Autologous stem-cell transplantation, Multiple myeloma, Clinical endpoint, Lenalidomide/administration & dosage, Prospective Studies, Elotuzumab, Lenalidomide, Melphalan, hematology, Hematopoietic Stem Cell Transplantation, Induction Chemotherapy, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, elotuzumab, Multiple Myeloma/therapy, Treatment Outcome, Research Design, 030220 oncology & carcinogenesis, Female, autologous stem cell transplant, Antibodies, Monoclonal, Humanized/administration & dosage, medicine.drug, Dexamethasone/administration & dosage, Adult, Melphalan/administration & dosage, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Maintenance Chemotherapy, 03 medical and health sciences, Young Adult, Internal medicine, Genetics, medicine, Humans, Aged, Chemotherapy, business.industry, medicine.disease, Survival Analysis, Consolidation Chemotherapy, 030104 developmental biology, Quality of Life, Bortezomib/administration & dosage, business, high-dose chemotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18b58d1361d94b3c6f22e13502a6ffd2Test
http://europepmc.org/articles/PMC6537200Test

المؤلفون: Hartmut Döhner, Verena I. Gaidzik, Jürgen Krauter, Michael Heuser, Michael Girschikofsky, Veronica Teleanu, Andrea Kündgen, Heinz-A. Horst, Arnold Ganser, Doris Kraemer, Bernd Hertenstein, Gerald Wulf, Mark Ringhoffer, Markus P. Radsak, Karin Mayer, Peter Paschka, Carsten Schwänen, Thomas Heinicke, Walter Fiedler, Elisabeth Lange, Axel Benner, Gudrun Göhring, Uwe M. Martens, Daniela Weber, Richard F. Schlenk, Gerhard Heil, Felicitas Thol, Lars Bullinger, Helmut R. Salih, Konstanze Döhner, Mridul Agrawal, Michael Pfreundschuh, Richard Greil, Michael Lübbert

المصدر: Leukemia. 32(7)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Myeloid, Dasatinib, Gastroenterology, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Biomarkers, Tumor, Humans, Cumulative incidence, Core binding factor acute myeloid leukemia, Aged, business.industry, Core Binding Factors, Remission Induction, Myeloid leukemia, Hematology, Middle Aged, medicine.disease, Confidence interval, Leukemia, Leukemia, Myeloid, Acute, Proto-Oncogene Proteins c-kit, 030104 developmental biology, medicine.anatomical_structure, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Toxicity, Mutation, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab879672cb2a22b0cf5551dfc0cd440Test
https://pubmed.ncbi.nlm.nih.gov/29720733Test

المؤلفون: Uwe M. Martens, Piotr Saramak, Hanno Riess, Stefano Cascinu, Katrin Roth, Wollf Schmiegel, John Bridgewater, Prabhu Rajagopalan, Marc Peeters, Henrik Seidel, Barrett H. Childs, Jean-Luc Van Laethem, Jacek Jassem, Marius Giurescu, Svein Dueland, Bohuslav Melichar, Vittorio Luigi Garosi, Paul Ross, Colin D. Weekes, Patrick Michl, Michael Teufel, Anke Schulz, Alberto Zaniboni, David Van Brummelen, Michael Haas

المساهمون: Van Laethem, J. -L., Riess, H., Jassem, J., Haas, M., Martens, U. M., Weekes, C., Peeters, M., Ross, P., Bridgewater, J., Melichar, B., Cascinu, S., Saramak, P., Michl, P., Van Brummelen, D., Zaniboni, A., Schmiegel, W., Dueland, S., Giurescu, M., Garosi, V. L., Roth, K., Schulz, A., Seidel, H., Rajagopalan, P., Teufel, M., Childs, B. H.

المصدر: Targeted oncology

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Antimetabolites, Antineoplastic, Bioinformatics, medicine.disease_cause, Deoxycytidine, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Pancreatic cancer, medicine, Humans, Pharmacology (medical), Sulfonamides, business.industry, Diphenylamine, Middle Aged, medicine.disease, Gemcitabine, Clinical trial, Pancreatic Neoplasms, 030104 developmental biology, Phase i ii, Treatment Outcome, Oncology, chemistry, 030220 oncology & carcinogenesis, Cancer research, Adenocarcinoma, Female, KRAS, Human medicine, business, Refametinib, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb7b5d7aa8ee952eeec33dfc4f153b0aTest
https://hdl.handle.net/10067/1526720151162165141Test

المؤلفون: Ulrich Gatzemeier, Igor Bondarenko, Yevhen Hotko, Jae Kyung Roh, Christopher Stroh, Cornelius Kortsik, Kenneth J. O'Byrne, Rodryg Ramlau, Carlos H. Barrios, Corinna Eschbach, Robert Pirker, Chih Teng Yu, Armin Schueler, Uwe M. Martens, Luis Paz-Ares, Joachim von Pawel, José Rodrigues Pereira, Ilhan Celik

المصدر: The Lancet Oncology. 12:795-805

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Population, Cetuximab, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Vinblastine, Vinorelbine, medicine.disease_cause, Proto-Oncogene Proteins p21(ras), Carcinoma, Non-Small-Cell Lung, Proto-Oncogene Proteins, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Medicine, Genetic Predisposition to Disease, education, Lung cancer, Aged, Neoplasm Staging, Retrospective Studies, education.field_of_study, Chemotherapy, business.industry, Antibodies, Monoclonal, Prognosis, medicine.disease, Immunohistochemistry, ErbB Receptors, Treatment Outcome, Clinical Trials, Phase III as Topic, ras Proteins, Biomarker (medicine), Female, KRAS, Cisplatin, business, medicine.drug, Necitumumab

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c2b7404580140d5c63357f430072e3Test
https://doi.org/10.1016/s1470-2045Test(11)70189-9

المؤلفون: Jamil Akkad, Sylvia Bochum, Uwe M. Martens

المصدر: Langenbeck's archives of surgery. 400(2)

مصطلحات موضوعية: Oncology, Male, Proteomics, medicine.medical_specialty, Bevacizumab, Colorectal cancer, medicine.medical_treatment, Angiogenesis Inhibitors, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Targeted therapy, Clinical Trials, Phase II as Topic, Cancer stem cell, Internal medicine, medicine, Biomarkers, Tumor, Humans, Molecular Targeted Therapy, Precision Medicine, Cetuximab, business.industry, Incidence, Cancer, Precision medicine, medicine.disease, Prognosis, digestive system diseases, Biomarker (cell), Gene Expression Regulation, Neoplastic, Treatment Outcome, Surgery, Female, business, Colorectal Neoplasms, medicine.drug, Forecasting

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21022655726aeceb4239a7d5b5bb6ba9Test
https://pubmed.ncbi.nlm.nih.gov/25701352Test